MedPath

The effect of pre-versus postdilution and pore size on the clearance of mid size mocules.

Completed
Conditions
10019280
shock after cardiac arrest
Registration Number
NL-OMON33818
Lead Sponsor
Onze Lieve Vrouwe Gasthuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

Patients with shock after cardiac arrest, treated with hypothermia

Exclusion Criteria

no CVVH available
contra-indication nadroparin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>As a marker for the clearance of smallmolecules, the concentration of<br /><br>creatinin, urea and ADMA will be measured. As a marker for the clearance of the<br /><br>midmolecules, the concentrations of &beta;2-microglobuline en Interleukine-6 will be<br /><br>measured.<br /><br>The concentrations will be measured in the arterial blood, postfilter blood and<br /><br>in the ultrafiltrate. We will measure the hematocrit in the bloodsamples.<br /><br><br /><br>Primary endpoint<br /><br>Effectivity of the clearance of midmolecules, 15 minutes and 6 hours<br /><br>after start HVHF, expressed as:<br /><br>o Sieving coefficient<br /><br>o Concentration filtrate* filtrateflow</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secundary endpoints<br /><br>· Effectivity of the clearance of midmolecules, 12 hours after start HVHF<br /><br>· Hemodynamics<br /><br>· Metabolic control<br /><br>· Other organfailure</p><br>
© Copyright 2025. All Rights Reserved by MedPath